Search
Search
Drug discovery organizations are generating more data than ever before, yet critical insights are often fragmented across systems, teams, and workflows.This disconnect can slow decision-making, increase costs, and limit the effective use of institutional knowledge.
Thermo Fisher Connect Discover Software by ASCEND™ from BenchSci addresses this challenge by linking AI-driven scientific insight directly with laboratory execution. By connecting hypothesis generation, experimental design, and real-world results, it enables a continuous learning cycle across the discovery process.
The result is a more integrated and efficient approach to R&D—where data, decisions, and outcomes are aligned within a single, connected system.
Learn how Connect Discover software strengthens your D-M-T-L cycle
Connect Discover is an AI-powered drug discovery software solution that links hypothesis generation, experimental design, and lab execution in a continuous learning loop.
Powered by BenchSci’s neuro-symbolic AI platform and Biological Evidence Knowledge Graph (BEKG), Connect Discover software enables scientists to generate evidence-based hypotheses and translate them into executable experiments. These experiments are then deployed through integrated laboratory systems, with results captured and fed back into the platform to inform future decisions.
At the core of Connect Discover software is a lab-in-the-loop architecture, which directly connects digital insight with physical experimentation. Rather than operating in isolation, AI-generated hypotheses are continuously validated through real-world lab execution, and experimental outcomes are systematically captured and reintegrated into the system. This creates a dynamic feedback loop where both scientific understanding and experimental precision improve over time.
This approach enables a true design–make–test–learn (DMTL) cycle within the discovery environment:
By continuously cycling through these stages, Connect Discover software transforms discovery from a linear process into a scalable, learning-driven system.
The platform is designed to operate within existing R&D environments, integrating with electronic lab notebooks (ELN), laboratory information management systems (LIMS), inventory, and procurement systems. Its vendor-agnostic architecture allows organizations to enhance current workflows without replacing established infrastructure.
By combining scientific insight, workflow execution, and continuous learning, Connect Discover software supports a connected, end-to-end discovery process.
Understand how this could apply to your research
Together, these capabilities support improved productivity, capital efficiency, and pipeline performance.
Ready to see how this could work in your environment?
Connect Discover software enables a closed-loop, lab-in-the-loop architecture that connects digital insights with physical execution:
AI powered by a Biological Evidence Knowledge Graph analyzes large-scale biomedical data to identify relevant targets, pathways, and hypotheses.
Insights are translated into structured, executable experimental plans aligned with available resources and constraints.
Experiments are deployed through integrated laboratory systems, including ELN, LIMS, inventory, and automation platforms.
Experimental data is automatically captured, structured, and made accessible across teams.
Results are incorporated back into the system, enabling continuous refinement of models and future experimental design.
This approach establishes a true design–make–test–learn (DMTL) cycle within the discovery environment.
See how this workflow could be applied in your lab environment?
R&D leadership (CSO, Head of Discovery, SVP R&D)
Scientific teams (Translational researchers, program leads, discovery scientists)
Data science and IT leaders
Laboratory operations
Connect Discover software powered by ASCEND from BenchSci is designed for large pharmaceutical and biotechnology organizations with complex discovery environments and established digital infrastructure.
Learn about your specific role and challenges
Connect Discover software supports AI for drug discovery by combining knowledge graph-based scientific reasoning with integrated laboratory workflows.
By structuring relationships between genes, pathways, diseases, and experimental data, the platform helps scientists move from hypothesis to experiment using connected tools and real-world evidence, improving confidence in experimental design and execution.
Unlike standalone AI lab software, Connect Discover software connects insights directly to execution by integrating with lab systems, workflows, and automation platforms.
Experimental design software helps scientists plan better experiments using evidence-based approaches, reducing redundant work and improving the quality of results.
Connect Discover software works together with the Thermo Fisher Connect Enterprise platform to connect scientific insight with laboratory execution. Connect Discover software generates evidence-based hypotheses and experimental designs using AI, while Connect Enterprise translates those designs into executable workflows across lab systems, including ELN, LIMS, instruments, and inventory.
This integration enables a seamless flow from hypothesis to experiment, helping to ensure that scientific intent is preserved while reducing manual effort and improving efficiency. Experimental results are then fed back into Connect Discover software to continuously improve future research decisions.
Connect Discover software is intended for pre-GxP research and experimental design, prior to execution in validated laboratory workflows.
Connect Discover software enables a more connected, data-driven approach to drug discovery, linking insight, execution, and learning across the R&D lifecycle.
Learn how Connect Discover software can support your discovery programs
For Research Use Only. Not for use in diagnostic procedures.